Nitroprusside: Clinical Trials

13 trials of Nitroprusside, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 4 terminated, 1 recruiting. 13 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 213Completed 8, Terminated 4, Recruiting 1
Phase 11Terminated 1
Phase 31Completed 1

Follow Nitroprusside: new trials by email Literature Review of Nitroprusside trials Research Report on Nitroprusside

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sodium Nitroprusside in Early Course Schizophrenia
Sodium Nitroprusside, 5% Dextrose solution - Schizophrenia, Schizoaffective Disorder
Phase 2TerminatedBeth Israel Deaconess Medical Center12022-03-142025-12-30
HeartPhone Cancer Survivors Trial 2019
HeartPhone app, Acetylcholine, Sodium Nitroprusside - Breast Cancer, Leukemia
Phase 1 / Phase 2TerminatedPenn State University22019-04-232026-02-27
Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)
Daprodustat, Darbepoetin alfa, Acetylcholine - Anaemia
Phase 2TerminatedGlaxoSmithKline62019-01-102024-03-27
Ketamine and Nitroprusside for Depression
Placebos, Ketamine, Nitroprusside - Depression
Phase 2CompletedIcahn School of Medicine at Mount Sinai402017-02-142020-07-02
Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV
Microneurography, Combat virtual reality video clip, Handgrip Exercise - Stress Disorders, Post-Traumatic
Phase 2RecruitingEmory University1342015-10-012026-05-18
A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia
sodium nitroprusside, Placebo - Schizophrenia
Phase 2CompletedMassachusetts General Hospital602015-05-012018-10-02
REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction
IC Adenosine, IC Sodium nitroprusside (SNP), Standard PCI - ST-elevation Myocardial Infarction (STEMI)
Phase 2CompletedUniversity Hospitals, Leicester2472011-10-012015-06-16
Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2)
nitroprusside, placebo infusion - Hypertension
Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)452009-01-012011-12-06
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction
adenosine, nitroprusside, placebo - Myocardial Infarction
Phase 2 / Phase 3CompletedCatholic University of the Sacred Heart2402008-01-012012-03-27
Effect of Strategy for Blood Pressure Control on Cerebral Oxygen Balance During Aortic Coarctation Repair: A Randomized Study
nitroprusside, nitroglycerine, sevoflurane - Cerebral Oxygenation
Phase 2CompletedUniversity Hospital, Ghent302007-10-012012-07-13
Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia
Sodium nitroprusside, Glucose solution - Schizophrenia
Phase 2CompletedUniversity of Sao Paulo202006-02-012012-03-08
Dose-response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room
Nitroprusside - Hypotension
Phase 2CompletedThe Emmes Company, LLC2112005-08-012024-01-02
Endothelial Hyperpolarization in Humans
Tetraethylammonium (TEA), L-NG-monomethyl Arginine (L-NMMA), Bradykinin - Hyperlipidemia
Phase 2TerminatedEmory University1742002-07-012018-08-15

Conditions studied

Schizophrenia (3)  ·  Anemia (1)  ·  Breast Neoplasms (1)  ·  Depression (1)  ·  Hyperlipidemias (1)  ·  Hypertension (1)  ·  Hypotension (1)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Myocardial Infarction (1)  ·  Psychotic Disorders (1)  ·  ST Elevation Myocardial Infarction (1)  ·  Stress Disorders, Post-Traumatic (1)

Sponsors

Emory University (2)  ·  Beth Israel Deaconess Medical Center (1)  ·  Catholic University of the Sacred Heart (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  GlaxoSmithKline (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Massachusetts General Hospital (1)  ·  Penn State University (1)  ·  The Emmes Company, LLC (1)  ·  University Hospital, Ghent (1)  ·  University Hospitals, Leicester (1)  ·  University of Sao Paulo (1)

Countries

United States (8)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Italy (1)

Top investigators

Scott Schulman, MD (2)  ·  Annelies Moerman, MD (1)  ·  Anthony H Gershlick, MBBS, FRCP (1)  ·  Arshed A Quyyumi, MD (1)  ·  Filippo Crea, MD (1)  ·  Giampaolo Niccoli, MD, PhD (1)  ·  Greg Hammer, MD (1)  ·  Gregory Hammer, MD (1)  ·  Jaime EC Hallak, Doctor (1)  ·  James Murrough, MD, PhD (1)  ·  Jeanie Park, MD (1)  ·  Maurizio Fava, MD (1)  ·  Paulo Lizano, MD, PhD (1)  ·  Roy Perlis, MD MSc (1)

Results publications

PMID 21555712, PMID 23631460, PMID 23699763, PMID 24675657, PMID 24925526, PMID 25252600, PMID 25648989, PMID 26217225, PMID 27147610, PMID 30916714, PMID 33522376, PMID 36005278

NIH funding

2017 (1), N01HD433867 (1), R01HL079115 (1)